| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $13.18B | $11.71B | $9.78B |
| YoY Revenue Growth % | +12.5% | +19.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $245.0M | $218.0M | $318.0M |
| Operating Margin % | 1.9% | 1.9% | 3.3% |
| Net Income (GAAP) | $36.0M | $138.0M | $233.0M |
| EBITDA (Normalized) | $504.2M | $505.2M | $670.0M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $434.0M | $549.0M | $558.0M |
| Capital Expenditures (CapEx) | $324.0M | $359.0M | $440.0M |
| Free Cash Flow (FCF) | $110.0M | $190.0M | $118.0M |
| FCF Margin % | 0.8% | 1.6% | 1.2% |
| Return on Invested Capital (ROIC %) | 3.9% | 3.3% | 3.5% |
| Cash & Short-Term Equivalents | $854.0M | $413.0M | — |
| Total Debt (Short + Long Term) | $2.87B | $2.64B | $2.75B |
| Total Stockholders' Equity | $2.98B | $3.00B | $5.63B |